preregistered
TL3 Research methods · Vienna, AT
I read protocols before results. It changes what you notice.
Joined 27 December 2024 · last posted 15h · groups: journal-club
126 posts, newest first. Showing up to 150.
-
A structured critique template this community uses — a second dataset Replied, post #52 · Evidence › Study critique · 27 Jul 2026 · 0 likes Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #95 · Practice › Interactions · 27 Jul 2026 · 5 likes Worth separating two things that post #91 runs together. Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by…
-
Batch numbers that do not match the vial label Replied, post #48 · Sourcing › Red flags · 24 Jul 2026 · 0 likes Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.
-
Aggregate verification data across the directory, with caveats Replied, post #64 · Sourcing › Independent verification · 22 Jul 2026 · 15 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Here for the analytics and not much else Replied, post #72 · Lounge › Introductions · 22 Jul 2026 · 0 likes Say hello. No question required. Introduce yourself if you want to give context for why you are here, or just introduce yourself because you like meeting people.
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #97 · Start Here › Welcome · 20 Jul 2026 · 14 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #66 · Outcomes › Body composition · 19 Jul 2026 · 24 likes Picking up post #63: that is the part I would want checked first. Visceral fat: DXA does not distinguish visceral (organ-associated) fat from subcutaneous fat. That…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #77 · Evidence › Journal club · 17 Jul 2026 · 0 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Aggregate verification data across the directory, with caveats Replied, post #51 · Sourcing › Independent verification · 16 Jul 2026 · 0 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #117 · Evidence › Journal club · 14 Jul 2026 · 0 likes Worth separating two things that post #113 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Publication patterns in the BPC-157 literature, examined Replied, post #35 · Compounds › Repair & healing peptides · 14 Jul 2026 · 2 likes For anyone arriving from search engines: this subcategory discusses published preclinical work and the absence of published clinical work. It does not endorse or…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #84 · Analytics › Method validation · 10 Jul 2026 · 23 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Alcohol: what is documented and what is folklore Replied, post #101 · Practice › Interactions · 9 Jul 2026 · 0 likes Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #72 · Sourcing › Independent verification · 7 Jul 2026 · 19 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #55 · Analytics › Home & field testing · 22 Jun 2026 · 17 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
-
Request: a per-category review queue Replied, post #52 · Meta › Feature requests · 22 Jun 2026 · 2 likes On post #48 — agreed on the reasoning, with one qualification. Feature scope: some requests are for the site itself (search, filtering, navigation). Some are for the…
-
Alcohol: what is documented and what is folklore Replied, post #68 · Practice › Interactions · 20 Jun 2026 · 1 like Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
-
The anatomy of a question that gets answered within an hour Replied, post #81 · Start Here › How to Ask · 17 Jun 2026 · 24 likes Lab result questions: state the result, the reference interval, and what else is on the same panel. A single flag on a single draw is usually uninformative without…
-
Rewriting my first post: a before-and-after, with commentary — what changed since Replied, post #7 · Start Here › How to Ask · 13 Jun 2026 · 6 likes This follows post #4 rather than contradicting it. Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is…
-
What would change my mind about repair peptides: a specific answer Replied, post #8 · Compounds › Repair & healing peptides · 9 Jun 2026 · 29 likes Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from one research group. That is not necessarily wrong — one group can do…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #116 · Practice › Interactions · 31 May 2026 · 0 likes Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
-
A parcel stationary at a customs facility for nine days Replied, post #62 · Sourcing › Logistics · 22 May 2026 · 8 likes Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and providing documentation (order, labelling) can help.…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #58 · Evidence › Preprints · 21 May 2026 · 4 likes post #57 is right about the mechanism and I think understates the practical bit. Do not build anything on a preprint that you would mind rebuilding: if the preprint…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #30 · Clinical › Comorbidities · 20 May 2026 · 0 likes Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and for reconstituted solutions. Discussing specific…
-
Injection volume, overload, and peak distortion Replied, post #12 · Analytics › HPLC & UHPLC · 19 May 2026 · 31 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
-
A 10 mg vial reconstituted three different ways, compared Replied, post #20 · Practice › Reconstitution · 15 May 2026 · 10 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
Alcohol: what is documented and what is folklore Replied, post #3 · Practice › Interactions · 5 May 2026 · 0 likes This follows post #2 rather than contradicting it. Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric…
-
Request: show the solution author in the topic list — what changed since Replied, post #64 · Meta › Feature requests · 3 May 2026 · 5 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Reading a home test result without over-claiming Replied, post #30 · Analytics › Home & field testing · 3 May 2026 · 0 likes This follows post #27 rather than contradicting it. False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not…
-
Request: show the solution author in the topic list — what changed since Replied, post #11 · Meta › Feature requests · 30 Apr 2026 · 0 likes Duplicate requests: if several people request the same feature, the requests often get merged. Check whether your feature has already been suggested before posting.
-
Resolution and tailing factor: real acceptance criteria Replied, post #2 · Analytics › HPLC & UHPLC · 24 Apr 2026 · 12 likes the opening post answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct…
-
Type 2 diabetes and the largest part of the evidence base Replied, post #77 · Clinical › Comorbidities · 21 Apr 2026 · 1 like Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
-
Run-in periods and the population they select Replied, post #102 · Evidence › Trials · 19 Apr 2026 · 7 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #91 · Practice › Reconstitution · 15 Apr 2026 · 2 likes Picking up post #88: that is the part I would want checked first. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a…
-
Adducts: sodium, potassium, and the peak you did not expect — does this still hold? Replied, post #100 · Analytics › Mass spectrometry · 8 Apr 2026 · 1 like Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
-
Tracking semaglutide's approved indications across jurisdictions, dated Started this topic · Compounds › Semaglutide · 8 Apr 2026 · 41 likes Tracking semaglutide's approved indications across jurisdictions, dated Writing it up because I had to work it out twice and would rather nobody else did. I have seen…
-
Pancreatitis history and the risk calculus Started this topic · Safety › Contraindications · 1 Apr 2026 · 0 likes Posting this under the heading it deserves: Pancreatitis history and the risk calculus Everything below is what sits behind that. Asking about a population rather than…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #111 · Pharmacology › Pharmacokinetics · 20 Mar 2026 · 2 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #69 · Outcomes › Body composition · 17 Mar 2026 · 1 like Coming back to post #67, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Type 2 diabetes and the largest part of the evidence base Replied, post #33 · Clinical › Comorbidities · 17 Mar 2026 · 18 likes Coming back to post #31, because the follow-up matters more than the original answer. Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the…
-
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #13 · Compounds › Semaglutide · 14 Mar 2026 · 32 likes post #12 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #58 · Compounds › Cagrilintide & amylin analogues · 11 Mar 2026 · 5 likes The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection. The trade-off of a fixed combination is that you cannot titrate the…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #11 · Practice › Dosing & titration · 7 Mar 2026 · 3 likes Coming back to post #9, because the follow-up matters more than the original answer. Reaching a dose and staying there for a year: the question of whether a stable dose…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #55 · Practice › Reconstitution · 27 Feb 2026 · 5 likes Picking up post #52: that is the part I would want checked first. Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #29 · Analytics › Impurities & related substances · 23 Feb 2026 · 3 likes Picking up post #26: that is the part I would want checked first. Related substances: compounds chemically related to the target peptide but not the target peptide…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #64 · Analytics › Impurities & related substances · 18 Feb 2026 · 7 likes post #63 is right about the mechanism and I think understates the practical bit. Related substances: compounds chemically related to the target peptide but not the…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #33 · Clinical › Special populations · 22 Jan 2026 · 14 likes Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal impairment. Consulting with a clinician familiar…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #47 · Sourcing › Red flags · 12 Jan 2026 · 0 likes Coming back to post #45, because the follow-up matters more than the original answer. Unresponsiveness: a supplier that does not reply to reasonable requests for…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #89 · Analytics › Home & field testing · 26 Dec 2025 · 27 likes This follows post #86 rather than contradicting it. Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work.…
-
Substitution between formats during a shortage Replied, post #122 · Access › Shortages · 23 Dec 2025 · 28 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
Tirzepatide's shorter half-life and its one practical consequence Replied, post #18 · Compounds › Tirzepatide · 1 Dec 2025 · 0 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
Pooling trials with different estimands — what changed since Replied, post #56 · Evidence › Meta-analyses · 25 Nov 2025 · 0 likes Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells you whether the effect is consistent or heterogeneous. A…
-
Second pass at: Programming during a large energy deficit Replied, post #93 · Nutrition & Training › Resistance training · 23 Nov 2025 · 0 likes Coming back to post #91, because the follow-up matters more than the original answer. Maintenance is the goal: preserving lean mass and strength during weight loss is…
-
Dead volume across syringe and needle combinations Replied, post #27 · Devices › Syringes & needles · 21 Nov 2025 · 7 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #36 · Sourcing › Vendor reports · 18 Nov 2025 · 10 likes On post #32 — agreed on the reasoning, with one qualification. Blind submission is worth the effort: have someone else relabel the sample so neither you nor the…
-
An inter-laboratory comparison on one lot, tabulated — what changed since Replied, post #16 · Analytics › Method validation · 16 Nov 2025 · 2 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
Robustness: the parameters worth deliberately varying Replied, post #3 · Analytics › Method validation · 15 Nov 2025 · 4 likes Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
-
EMA product information as a primary source Replied, post #60 · Regional › European Union · 12 Nov 2025 · 24 likes This follows post #57 rather than contradicting it. Pharmacy practice: pharmacies in different EU countries differ in conservatism about irregular prescriptions. Some…
-
[2026 update] What steady state means for the decision to escalate Replied, post #5 · Practice › Dosing & titration · 4 Nov 2025 · 12 likes I read post #3 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Availability by country, dated, with primary sources Replied, post #39 · Access › International · 30 Oct 2025 · 0 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #51 · Safety › Adverse events · 24 Oct 2025 · 4 likes Worth separating two things that post #47 runs together. Where to report: in many countries there is a pharmacovigilance system where adverse events can be reported.…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #8 · Pharmacology › Pharmacokinetics · 24 Oct 2025 · 16 likes post #7 answers the question as asked. The question underneath it is different. Hepatic metabolism: the degree to which each compound is hepatically metabolised versus…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #66 · Practice › Dosing & titration · 22 Oct 2025 · 11 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #13 · Compounds › Oral incretins · 21 Oct 2025 · 27 likes This follows post #10 rather than contradicting it. Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no…
-
[2026 update] Long-time reader, first-time poster Replied, post #19 · Lounge › Introductions · 21 Oct 2025 · 3 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Payment mechanics and the recovery options that do not exist Replied, post #16 · Sourcing › Payments · 19 Oct 2025 · 21 likes Escrow services: some third-party services hold payment until the buyer confirms receipt. They add cost but reduce risk if the supplier is unknown.
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #46 · Compounds › Tirzepatide · 16 Oct 2025 · 1 like I read post #44 twice before replying, because I had assumed the opposite. SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance…
-
What a 2 ppm match establishes, and what it does not Replied, post #58 · Analytics › Mass spectrometry · 9 Oct 2025 · 19 likes post #57 is right about the mechanism and I think understates the practical bit. Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS,…
-
Availability by country, dated, with primary sources Replied, post #9 · Access › International · 3 Oct 2025 · 12 likes Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not…
-
Temperature loggers worth the money — the long version Replied, post #48 · Devices › Cold chain · 29 Sep 2025 · 6 likes Domestic refrigeration: most lyophilised peptides are stored at 2–8 °C (35–46 °F). That is standard refrigerator temperature. Check your refrigerator's actual…
-
Temperature logging at home: what is worth the effort Replied, post #2 · Practice › Storage & stability · 21 Sep 2025 · 24 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
How to read a forest plot, properly, from scratch Replied, post #26 · Evidence › Trials · 11 Sep 2025 · 30 likes Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in. HbA1c is a surrogate for long-term glucose control and the…
-
Revisiting: German, French and Dutch differences, compared Replied, post #69 · Regional › European Union · 7 Sep 2025 · 28 likes Pharmacy practice: pharmacies in different EU countries differ in conservatism about irregular prescriptions. Some will decline a prescription they consider irregular;…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #127 · Compounds › Secretagogues & GH axis · 3 Sep 2025 · 7 likes Picking up post #124: that is the part I would want checked first. Development history is more informative than speculation: ipamorelin was investigated clinically for…
-
Second pass at: The mass-error checker and its intended scope Replied, post #8 · Data & Tools › Calculators · 30 Aug 2025 · 0 likes Storage lookup: which conditions (temperature, time) are you considering storing in, and how much stability loss is expected? The calculator gives a rough estimate…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #106 · Evidence › Journal club · 24 Aug 2025 · 1 like post #105 answers the question as asked. The question underneath it is different. SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an…
-
Managing an unplanned gap in supply — what changed since Replied, post #32 · Access › Shortages · 6 Aug 2025 · 0 likes Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
-
A comparison of home results against a laboratory result on the same vial Replied, post #21 · Analytics › Home & field testing · 4 Aug 2025 · 0 likes Picking up post #18: that is the part I would want checked first. Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour result.…
-
A ten-fold dose error caught before injection — one year on Replied, post #95 · Devices › Syringes & needles · 3 Aug 2025 · 0 likes Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For subcutaneous injection, 27-30G is typical. Finer needles take…
-
Revisiting: Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #20 · Practice › Administration · 31 Jul 2025 · 18 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
-
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #22 · Analytics › COA interpretation · 13 Jul 2025 · 1 like I read post #20 twice before replying, because I had assumed the opposite. Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent…
-
Second pass at: Two scans six weeks apart on different machines: a cautionary tale Replied, post #2 · Outcomes › Body composition · 12 Jul 2025 · 10 likes Bioelectric impedance analysis: less precise than DXA and strongly affected by hydration state. Not reliable for detecting month-to-month changes. Useful for trend over…
-
Request: a diff view for wiki revisions — the long version Replied, post #17 · Meta › Feature requests · 9 Jul 2025 · 3 likes Worth separating two things that post #13 runs together. Community support: if other people support your request, they can reply with "+1" or "I would use that too".…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #66 · Evidence › Journal club · 4 Jul 2025 · 0 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Sequence verification for an obscure compound: how it is done Replied, post #80 · Compounds › Other compounds · 2 Jul 2025 · 8 likes Coming back to post #78, because the follow-up matters more than the original answer. Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that…
-
Reading a regulatory notice rather than an article about it — what changed since Replied, post #31 · Sourcing › Regulatory · 30 Jun 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Reading a chromatogram someone posted without axes Replied, post #52 · Analytics › HPLC & UHPLC · 30 Jun 2025 · 0 likes Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition. 280 nm detects aromatic residues and is strongly…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #70 · Pharmacology › Pharmacokinetics · 28 Jun 2025 · 11 likes On post #66 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Reading a supplier's product description as a marketing document Replied, post #32 · Compounds › Other compounds · 11 Jun 2025 · 0 likes Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound gets different names from different suppliers. If…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #54 · Clinical › Comorbidities · 1 Jun 2025 · 0 likes Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not…
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #13 · Practice › Dosing & titration · 15 May 2025 · 5 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Reading a trial's population section before its results — does this still hold? Replied, post #48 · Evidence › Trials · 28 Apr 2025 · 14 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #20 · Sourcing › Independent verification · 27 Apr 2025 · 0 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #15 · Evidence › Trials · 20 Apr 2025 · 15 likes On post #11 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
When "no data" is the complete and final answer Replied, post #149 · Compounds › Other compounds · 15 Apr 2025 · 11 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
-
Asking about a compound your prescriber has not heard of Replied, post #12 · Clinical › Prescriber conversations · 7 Apr 2025 · 0 likes Discussing side effects: be specific. "Nausea" is less useful than "I have nausea worst 24 to 36 hours after injection, severity 2 to 3 out of 4, stable over weeks".…
-
Why a pen's dose steps are fixed and what that costs you — one year on Replied, post #8 · Devices › Pens & autoinjectors · 6 Apr 2025 · 0 likes Visibility of the dose: some pens allow you to see the insulin remaining; others do not. Keeping track using the dose counter is important if visibility is limited.
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #38 · Practice › Interactions · 6 Apr 2025 · 0 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #6 · Evidence › Trials · 4 Apr 2025 · 14 likes Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
A supplier who responds to a discrepancy with silence Replied, post #2 · Sourcing › Red flags · 30 Mar 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #46 · Evidence › Journal club · 16 Mar 2025 · 1 like Worth separating two things that post #42 runs together. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence to the…
-
Adjudicated events and why the definition matters — the long version Replied, post #36 · Evidence › Trials · 6 Mar 2025 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Consistent declarations and why they matter more than clever ones Replied, post #132 · Sourcing › Logistics · 5 Mar 2025 · 0 likes At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #39 · Practice › Reconstitution · 2 Mar 2025 · 4 likes This follows post #36 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #53 · Compounds › Semaglutide · 6 Feb 2025 · 17 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
-
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #22 · Devices › Syringes & needles · 23 Jan 2025 · 14 likes I read post #20 twice before replying, because I had assumed the opposite. Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL.…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #17 · Compounds › Semaglutide · 4 Jan 2025 · 0 likes I read post #15 twice before replying, because I had assumed the opposite. Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects.…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #103 · Access › Insurance & coverage · 4 Jan 2025 · 0 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
Pancreatitis history and the risk calculus — a second dataset Replied, post #17 · Safety › Contraindications · 21 Dec 2024 · 0 likes Pregnancy: these compounds are not approved for pregnancy. The potential risks outweigh potential benefits. Planning windows and washout (several months) are the…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #35 · Practice › Reconstitution · 4 Dec 2024 · 15 likes Picking up post #32: that is the part I would want checked first. Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #113 · Clinical › Prescriber conversations · 2 Dec 2024 · 6 likes Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #150 · Compounds › Repair & healing peptides · 26 Nov 2024 · 4 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Converting between mg/mL and units per dose, both directions Replied, post #100 · Practice › Reconstitution · 23 Nov 2024 · 1 like Picking up post #97: that is the part I would want checked first. Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #122 · Compounds › Other compounds · 17 Nov 2024 · 5 likes Picking up post #119: that is the part I would want checked first. When "no data" is the complete and final answer: if there is no published human data on a compound,…
-
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #6 · Sourcing › Independent verification · 22 Oct 2024 · 0 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #55 · Clinical › Comorbidities · 18 Oct 2024 · 9 likes I read post #53 twice before replying, because I had assumed the opposite. Chronic kidney disease: compounds in this class have renal benefit in people with kidney…
-
Progressive overload when the scale is falling — one year on Replied, post #127 · Nutrition & Training › Resistance training · 5 Oct 2024 · 0 likes Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies on an energy deficit. Consistency beats intensity when recovery…
-
Tirzepatide storage and stability: what is published versus what is assumed — does this… Replied, post #2 · Compounds › Tirzepatide · 24 Sep 2024 · 0 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
Second pass at: Albumin binding and how it produces a long half-life Replied, post #4 · Pharmacology › Pharmacokinetics · 23 Sep 2024 · 3 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Gallbladder disease risk with rapid weight loss Replied, post #4 · Clinical › Comorbidities · 26 Aug 2024 · 4 likes Coming back to post #3, because the follow-up matters more than the original answer. Bariatric surgery history: altered anatomy after surgery affects absorption. That…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #46 · Nutrition & Training › Hydration & electrolytes · 18 Aug 2024 · 12 likes Picking up post #43: that is the part I would want checked first. Magnesium: deficiency during weight loss is common and symptoms (fatigue, muscle cramps) are…
-
Guidelines revision: what changed and why Replied, post #20 · Meta › Announcements · 25 Jul 2024 · 12 likes Staff-only posts: some announcements are visible only to staff (concerning internal operations). Members see public announcements.
-
Journal club: FLOW and the renal composite, component by component Replied, post #56 · Evidence › Journal club · 14 Jul 2024 · 20 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #126 · Practice › Dosing & titration · 10 Jul 2024 · 3 likes This follows post #123 rather than contradicting it. Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure,…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #39 · Practice › Dosing & titration · 7 Jul 2024 · 6 likes On post #35 — agreed on the reasoning, with one qualification. Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #8 · Practice › Interactions · 6 Jul 2024 · 14 likes I read post #6 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so…